Iron deposition and progression of disease in chronic hepatitis C: Role of interface hepatitis, portal inflammation, and HFE missense mutations

American Journal of Clinical Pathology

Volumn 113, Issue 4, 2000, Pages 546-554

  Pirisi, Mario ^a   Scott, Cathryn A ^b   Avellini, Claudio ^b   Toniutto, Pierluigi ^b   Fabris, Carlo ^b   Soardo, Giorgio ^b   Beltrami, Carlo A ^b   Bartoli, Ettore ^b  

^a Ospedale di Careggi   (Italy)

^b NONE

Author keywords

Chronic hepatitis C; Grade; Hereditary hemochromatosis; HFE mutations; Histologic activity index; Iron; Stage

Indexed keywords

FERRITIN; HEPATITIS C ANTIBODY; IRON; VIRUS RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME IMMUNOASSAY; GENE; GENE MUTATION; HEPATITIS C; HUMAN; HUMAN TISSUE; IRON METABOLISM; IRON OVERLOAD; LIVER BIOPSY; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PORTAL VEIN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034056296     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/trb1-jxuj-l9r6-9nhx     Document Type: Article

References (42)

1. Pietrangelo A. Iron, oxidative stress, and liver fibrogenesis. J Hepatol. 1998;28:8-13.
2. Bonkovsky HL, Banner BF, Lambrecht RW, et al. Iron in liver diseases other than hemochromatosis. Semin Liver Dis. 1996;16:65-82.
3. Ludwig J, Hashimoto E, Porayko MK, et al. Hemosiderosis in cirrhosis: A study of 447 native livers. Gastroenterology. 1997;112:882-888.
4. Bonkovsky HL, Banner BF, Rothman AL. Iron and chronic viral hepatitis. Hepatology. 1997;25:759-768.
5. Olynyk J, Reddy KR, Di Bisceglie AM, et al. Hepatic iron concentration as a predictor of response to interferon alpha therapy in chronic hepatitis C. Gastroenterology. 1995;108:1104-1109.
6. Ikura Y, Morimoto H, Johmura H, et al. Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C. Am J Gostroenterol. 1996;91:1367-1373.
7. Kaji K, Nakanuma Y, Sasaki M, et al. Hemosiderin deposition in portal endothelial cells: a novel hepatic hemosiderosis in chronic viral hepatitis B and C. Hum Pathol. 1995;26:1080-1085.
8. Barton AL, Banner BF, Cable EE, et al. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy. Am J Gin Pathol. 1995;103:419-424.
9. Haque S, Chandra B, Gerber MA, et al. Iron overload in patients with chronic hepatitis C: a clinicopathologic study. Hum Pathol. 1996;27:1277-1281.
10. Banner BF, Barton AL, Cable EE, et al. Detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C. Mod Pathol. 1995;8:232-238.
11. Kaserer K, Fiedler R, Steindl P, et al. Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C. Histopathology. 1998;32:454-461.
12. Fargion S, Fracanzani AL, Sampietro M, et al. Liver iron influences the response to interferon alpha therapy in chronic hepatitis C. Eur J Gastroenterol Hepatol. 1997;9: 497-503.
13. Beinker NK, Voigt MD, Arendse M, et al. Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C. J Hepatol. 1996;25:633-638.
14. Riggio O, Montagnese F, Fiore P, et al. Iron overload in patients with chronic viral hepatitis: how common is it? Am J Gastroenterol. 1997;92:1298-1301.
15. Searle JW, Kerr JFR, Halliday JW, et al. Iron storage disease. In: MacSween RNM, Anthony PP, Scheuer PJ, et al, eds. Pathology of the Liver. 3rd ed. Edinburgh, Scotland: Churchill Livingstone; 1994:219-241.
16. Bacon B, Powell LW, Adams PC, et al. Molecular medicine and hemochromatosis: at the crossroads. Gostroenterology. 1999;116:193-207.
17. Feder JN, Penny DM, Irrinki A, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA. 1998;95:1472-1477.
18. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399-408.
19. Hengeveld P, Zuyderhoudt FMJ, Jobsis AC, et al. Some aspects of iron metabolism during acute viral hepatitis. Hepatogastroenterology. 1982;29:138-141.
20. Senba M, Nakamura T, Itakura H. Statistical analysis of relationship between iron accumulation and hepatitis B surface antigen. Am J Clin Pathol. 1985;84:340-342.
21. Lefkowitch JH, Yee HT, Sweeting J, et al. Iron-rich foci in chronic viral hepatitis. Hum Pathol. 1998;29:116-118.
22. Edwards CQ, Kushner JP. Screening for haemochromatosis. N Engl J Med. 1993;328:1616-1620.
23. Deugnier Y, Battistelli D, Jouanolle H, et al. Hepatitis B virus infection markers in genetic haemochromatosis: a study of 272 patients. J Hepatol. 1991;13:286-290.
24. Conte D, Piperno A, Mandelli C, et al. Clinical, biochemical and histologic features of primary hemochromatosis: a report of 67 cases. Liver. 1986;6: 310-315.
25. Piperno A, Fargion S, D'Alba R, et al. Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection. Hepatology. 1992;16:364-368.
26. Gehrke SG, Riedel D, Fitscher BA, et al. Prevalence of mutations in the hemochromatosis gene HLA-H in patients with chronic hepatitis C: influence on histological activity, iron metabolism, and response to interferon therapy. Hepatology. 1997;26:410A. Abstract.
27. Hezode C, Cazeneuve C, Coué C, et al. Hemochromatosis C282Tyr mutation and liver iron overload in patients with chronic active hepatitis C [letter]. Hepatalogy. 1998;27:306.
28. Smith BC, Gorve J, Guzail MA, et al. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology. 1998;27:1695-1699.
29. Kazemi-Shirazi L, Datz C, Maier-Dobersberger T, et al. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology. 1999;116:127-134.
30. Piperno A, Vergani A, Malosio I, et al. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations. Hepatology. 1998;28:1105-1109.
31. Piperno A, Sampietro M, Pietrangelo A, et al. Heterogeneity of hemochromatosis in Italy. Gastroenterology. 1998;114:996-1002.
32. Shaheen NJ, Bacon BR, Grimm IS. Clinical characteristics of hereditary hemochromatosis patients who lack the C282Y mutation. Hepatology. 1998;28:526-529.
33. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696-699.
34. Toniutto P, Pirisi M, Tisminetzky SG, et at. Discordant results from hepatitis C virus genotyping by procedures based on amplification of different genomic regions. J Clin Microbiol 1996;34:2382-2385.
35. Jazwinska EC, Cullen LM, Busfield F, et al. Hemochromatosis and HLA-H. Nat Genet. 1996;14:249-251.
36. Berg T, Hopf U, Strk K, et al. Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C: correlation with clinical and virological parameters. J Hepatol. 1997;26:484-491.
37. Simmonds P. Variability of hepatitis C virus. Hepatology. 1995;21:570-583.
38. Dhillon AP, Dusheiko GM. Pathology of hepatitis C virus infection. Histopathology. 1995;26:297-309.
39. Brissot P, Bourel M, Herry D, et al. Assessment of liver iron content in 271 patients: a revaluation of direct and indirect methods. Gastroenterology. 1981;80:557-565.
40. Seef LB. The natural history of hepatitis C: a quandary. Hepatology. 1998;28:1710-1712.
41. Moirand R, Jouanolle AM, Brissot P, et al. Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives. Gastroenterology. 1999;116:372-377.
42. Rianchi L, Gudat F. Chronic hepatitis. In: MacSween RNM, Anthony PP, Scheuer PJ et al, eds. Pathology of the Liver. 3rd ed. Edinburgh, Scotland: Churchill Livingstone; 1994: 349-395.